57.20
+0.07
+(0.12%)
At close: March 24 at 1:47:47 PM CST
Insider Purchases Last 6 Months
Shares | Transactions | |
---|---|---|
Purchases | 0 | 0 |
Sales | -- | 0 |
Net Shares Purchased (Sold) | 0 | 0 |
Total Insider Shares Held | 6.07M | -- |
% Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
Shares | |
---|---|
Net Shares Purchased (Sold) | -- |
% Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
Insider | Transaction | Type | Value | Date |
---|---|---|---|---|
SCHOEN ERIC J. Chief Financial Officer | Sale at price 3.82 - 3.86 per share. | Indirect | 238,468 | Nov 29, 2024 |
KUPIEC JAMES WILLIAM Officer | Sale at price 3.87 per share. | Direct | 15,480 | Nov 29, 2024 |
SCHOEN ERIC J. Chief Financial Officer | Conversion of Exercise of derivative security at price 1.18 per share. | Direct | 59,000 | Nov 29, 2024 |
ROBERTSON SANFORD R Director | Stock Gift at price 0.00 per share. | Direct | 0 | May 16, 2024 |
ROBERTSON SANFORD R Director | Conversion of Exercise of derivative security at price 22.00 per share. | Direct | 1,518,000 | Apr 26, 2024 |
BARRY RICHARD J Director | Conversion of Exercise of derivative security at price 22.00 per share. | Indirect | 3,873,870 | Apr 23, 2024 |
KUPIEC JAMES WILLIAM Officer | Conversion of Exercise of derivative security at price 22.00 per share. | Direct | 33,000 | Apr 18, 2024 |
SCHOEN ERIC J. Chief Financial Officer | Conversion of Exercise of derivative security at price 22.00 per share. | Direct | 33,000 | Apr 17, 2024 |
ROBERTSON SANFORD R Director | Purchase at price 17.45 per share. | Direct | 523,500 | Aug 23, 2023 |
BARRY RICHARD J Director | Purchase at price 16.65 - 16.80 per share. | Indirect | 307,928 | Aug 22, 2023 |
SCANNON PATRICK J M.D., PH.D. Director | Conversion of Exercise of derivative security at price 0.95 per share. | Direct | 950 | Jun 12, 2023 |
BARBIER REMI Chief Executive Officer | Conversion of Exercise of derivative security at price 16.87 per share. | Indirect | 1,445,978 | May 24, 2023 |
ROBERTSON SANFORD R Director | Conversion of Exercise of derivative security at price 16.66 - 19.60 per share. | Direct | 165,170 | May 10, 2023 |
GUSSIN ROBERT Z Director | Conversion of Exercise of derivative security at price 16.66 - 19.60 per share. | Direct | 165,170 | May 1, 2023 |
Related Tickers
12X1.F Anavex Life Sciences Corp.
7.85
-0.83%
HOTH Hoth Therapeutics, Inc.
0.8064
-2.27%
IVVD Invivyd, Inc.
0.5140
-2.11%
SANA Sana Biotechnology, Inc.
1.7000
-6.08%
AVXL Anavex Life Sciences Corp.
9.12
+3.40%
SRPT Sarepta Therapeutics, Inc.
54.42
-0.38%
MURA Mural Oncology plc
2.4100
+133.98%
MRNA Moderna, Inc.
26.24
-2.09%
NVAX Novavax, Inc.
6.39
-0.31%